tiprankstipranks
Trending News
More News >
WPD Pharmaceuticals (WPDPF)
OTHER OTC:WPDPF
US Market

WPD Pharmaceuticals (WPDPF) Income Statement

Compare
10 Followers

WPD Pharmaceuticals Income Statement

Last quarter (Q3 2024), WPD Pharmaceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, WPD Pharmaceuticals's net income was C$47.52K. See WPD Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ -24.44KC$ -290.22KC$ -391.77K-
Operating Expenses
C$ 268.91KC$ 2.30MC$ 6.04MC$ 8.07MC$ 13.18M
Depreciation and Amortization
C$ 332.00C$ 24.44KC$ 290.22KC$ 391.77KC$ 100.73K
EBITDA
C$ -40.43KC$ 4.05MC$ -5.24MC$ -7.11MC$ -11.45M
Operating Income
C$ -268.91KC$ -2.33MC$ -6.33MC$ -8.46MC$ -12.07M
Other Income/Expenses
C$ 188.83KC$ 6.19MC$ 708.61KC$ 935.77KC$ 459.56K
Pretax Income
C$ -80.08KC$ 3.86MC$ -5.62MC$ -7.52MC$ -11.61M
Net Income
C$ -80.08KC$ 3.86MC$ -5.62MC$ -7.52MC$ -12.78M
Per Share Metrics
Basic EPS
C$ 0.00C$ 0.03C$ -0.05C$ -0.07C$ -0.18
Diluted EPS
C$ 0.00C$ 0.03C$ -0.05C$ -0.07C$ -0.18
Weighted Average Shares Outstanding
113.59M 113.44M 113.44M 113.13M 72.15M
Weighted Average Shares Outstanding (Diluted)
113.44M 113.44M 113.44M 113.13M 72.15M
Currency in CAD

WPD Pharmaceuticals Earnings and Revenue History